About 100 reports

  • Global respiratory disease testing market by test
  • GLOBAL RESPIRATORY DISEASE TESTING MARKET 2014-2019 ($ BILLIONS)

About respiratory disease testing The respiratory system of the body plays a vital role in eliminating carbon dioxide and toxic wastes, regulates the temperature, and establishes a stabilized blood acid-alkaline balance. Respiratory diseases such as asthma, bronchitis, COPD occur due to acute or chronic defects in the respiratory system....

  • Respiratory Disease
  • World
  • Alere Inc.
  • CareFusion Corporation
  • Nihon Kohden Corporation

Respiratory Diseases Drugs Global Market Report 2018 ##.

  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • World

2018 Competing in the Global Respiratory Disease Testing Market Complete report $##, ##.

  • Respiratory Disease
  • Europe
  • Japan
  • World
  • Demand

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 ##.

  • Cattle
  • Livestock
  • Respiratory Disease
  • World
  • Market Size
  • RESPIRATORY DISEASES
  • GLOBAL RESPIRATORY DISEASES DRUGS MARKET COMPETITIVE LANDSCAPE

The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases.Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Pharmaceutical drugs are intended for human or...

  • Respiratory Disease
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

Growing prevalence of respiratory diseases such as COPD, asthma is increasing the demand for respiratory disease testing/ diagnostic in North American countries.

  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • United States
  • Demand

Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) FIG. ## Germany Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) FIG. ## Rest of Europe Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Millio

  • Chronic Disease
  • Respiratory Disease
  • United States
  • World
  • Market Size
  • Respiratory Drugs Market Geography Regional and Country Comparison
  • VECTURA MERGED WITH SKYEPHARMA

Respiratory diseases drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic and acute bronchitis, emphysema and cystic fibrosis. Some of the major drugs in the market include antimuscarinics, corticosteroids, Codral®, Coldrex®...

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • RISE IN HOSPITAL ADMISSION FOR RESPIRATORY DISEASES
  • GROWING INCIDENCE OF CHRONIC RESPIRATORY DISEASES

About Respiratory Disposable Devices Safe clinical practices during a patient's hospital stay can reduce the risk of hospital-acquired infections (HAIs), which constitute a major threat to the patient's safety. The governments in developed and developing countries are giving due importance to patient safety during invasive and non-invasive...

  • Respiratory Disease
  • World
  • Market Size
  • CareFusion Corporation
  • Teleflex Incorporated
  • RISE IN PREVALENCE OF RESPIRATORY DISEASES
  • INCREASING AWARENESS ABOUT RESPIRATORY DISEASES

About Respiratory Ailments Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most prevalent worldwide. Environmental pollution, changing lifestyles, and hereditary factors are some of the common causes of respiratory diseases....

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • SHARE OF DISABILITY ADJUSTED LIFE YEARS FROM CHRONIC RESPIRATORY DISEASE, 2010
  • SHARE OF DEATHS FROM CHRONIC RESPIRATORY DISEASE, 2010

Executive Summary Due to rise in tobacco intake and rise in pollution with escalating CO2 emissions, market for Respiratory Care Devices is anticipated to rise by 10.90% up till 2021. Growth in Ageing Population and high risk of respiratory disorders, rise in demand for handheld and portable device and rising incidence of Chronic...

  • Respiratory Disease
  • World
  • Market Size
  • Astra Group
  • Becton Property Group
  • NASAL CANNULA MARKET IN AMERICAS
  • MARKET CHALLENGES

It is one of the leading companies offering advanced respiratory products.

  • Respiratory Device
  • Respiratory Disease
  • World
  • Forecast
  • Teleflex Incorporated
  • Rising incidence of chronic respiratory diseases
  • MARKET DRIVERS

About Medical Suction Devices Medical suction devices are machines used to clear the airway from blood, saliva, vomit, or other secretions in individuals. Medical suction pumps are also used in endoscopy, wound drainage, and other applications where a reliable and precise suction source are needed. The medical suction devices...

  • Hospital
  • Respiratory Disease
  • United States
  • World
  • Forecast
  • Growing a diversified business Simplifying the operating model for increasing efficiency
  • YOY REVENUE COMPARISON OF TOP DRUGS FOR ALLERGIC RHINITIS 2012-2014 ($ BILLIONS)

About Allergic Rhinitis Drugs Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea,...

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • GLOBAL P.M 2.5 AIR POLLUTION, MEAN ANNUAL EXPOSURE, BY SELECT COUNTRIES, 2015
  • BRAZIL OXYGEN THERAPY EQUIPMENT MARKET, BY APPLICATION

GROWING PREVALENCE OF CHRONIC RESPIRATORY DISEASES IN INDIA.

  • Respiratory Disease
  • World
  • Inogen, Inc.
  • Invacare Corporation
  • Philips Respironics, Inc.
  • Availability of nebulizer substitutes
  • MARKET CHALLENGES

About Nebulizer Nebulizers are medical devices used to administer drugs. The drugs are converted into a form of aerosol and delivered directly into the lungs. Nebulizers use compressed air or oxygen or ultrasonic power to break drug solutions into aerosol droplets, which can be inhaled using the mouthpiece of the device. They...

  • Healthcare
  • Respiratory Disease
  • World
  • Forecast
  • Koninklijke Philips N.V.
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, CLINICAL TRIAL SIZE BY STAGE OF
  • 4.4.3.3 Molecular Target

Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers Summary Respiratory disorders, which affect components of the respiratory system such as the...

  • Respiratory Disease
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Healthcare spending as percentage of GDP 2014
  • Identifying factors impacting market growth

About Smart Inhaler Technology The smart inhaler technology uses sensors and requires a smartphone or a computer-based app, which can be integrated into any metered-dose inhaler (MDI) or dry-powder inhaler (DPI) inhaler to convert it into a smart inhaler. The sensors used in smart inhalers can be connected to the user’s...

  • Respiratory Disease
  • United States
  • World
  • Forecast
  • Adherium Limited
  • INHALERS MARKET IN GLOBAL ASTHMA DRUG-DELIVERY DEVICES MARKET 2015-2020 ($ MILLIONS)
  • MARKET SIZE AND FORECAST

About Asthma Therapeutics Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity...

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • VENTURI MASKS MARKET IN APAC
  • Venturi masks market in APAC is expected to grow at a CAGR of 17.06% during the forecast period.

The rising older population is linked to the increasing patient pool with low mobility and need for long-term care for Alzheimer' s disease and other chronic respiratory diseases.

  • Hospital
  • Oxygen Device
  • Respiratory Disease
  • World
  • Forecast

Introduction to Asthma and COPD Therapies ##. ## The Pharmaceutical Industry: A Very Brief Overview ##. ## Classifying Respiratory Diseases: Obstructive and Restrictive ##. ##. ## Classifying Respiratory Diseases: Obstructive and Restrictive ##. ## What is Asthma?

  • Respiratory Disease
  • Therapy
  • World
  • Market Shares
  • Market Size
  • BREAKTHROUGH IN COPD RESEARCH

They treat cystic fibrosis, asthma, COPD, and other respiratory diseases.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • OTHER PROMINENT VENDORS

It undertakes the discovery and development of drugs for the treatment of respiratory diseases.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • ADULT POPULATION WITH SINUSITIS AND CHRONIC RHINITIS IN US 2014 (MILLION)

Respiratory diseases such as sinusitis and hay fever/ rhinitis are some of the diseases that affect a large population and are therefore a major concern.

  • Allergy Drug
  • Respiratory Disease
  • World
  • Novartis AG
  • Sanofi S.A.
  • 6.1 Savara Inc.
  • 6.1.1 Business Overview

Around one third of people identified with PAP disease with unknown cause, will improve without treatment.

  • Respiratory Disease
  • World
  • Forecast
  • Market Size
  • Mast Therapeutics, Inc.

Discovers drugs to treat chronic respiratory diseases, including asthma and allergic rhinitis.

  • Respiratory Disease
  • World
  • Allergy Therapeutics plc
  • Merck & Co., Inc.
  • Stallergenes SA
  • Strengths
  • 5.1 DISEASE BACKGROUND

CHRONIC RESPIRATORY DISEASES.

  • Respiratory Disease
  • Australia
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • ACQUISITIONS IN SMART INHALER MARKET
  • 2.1 Global Smart Inhaler Market by Value

Smart Inhalers are defined as digitally operated inhalers equipped with the sensors that are used by patient for monitoring and tracking the medication usage. These are the innovative solution of digital technology intended to improve the management of the respiratory diseases such as Asthma and COPD. These are either add-on sensor...

  • Respiratory Disease
  • Adherium Limited
  • Bluetooth SIG, Inc.
  • GlaxoSmithKline plc
  • Novartis AG

Allergic diseases are one of the fastest-growing chronic diseases globally.

  • Respiratory Disease
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • 3.3.1 DRIVERS AND OPPORTUNITIES
  • 3.7.1 DUBBED COUGHAWARE FROM QUVIUM & DSP

Respiratory Care Diagnostic devices are the devices which are used for the diagnosis of respiratory diseases such as Pneumonia, Asthma, Bronchitis, Sleep Apnea, cystic and pulmonary fibrosis, Tuberculosis, COPD (Chronic Obstructive Pulmonary Disease) etc. The Respiratory Care Device global market is segmented based on the products, applications,...

  • Respiratory Disease
  • World
  • Market Size
  • Medtronic, Inc.
  • ResMed Inc.